BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28102526)

  • 1. Hormonal and reproductive factors and the risk of ovarian cancer.
    Koushik A; Grundy A; Abrahamowicz M; Arseneau J; Gilbert L; Gotlieb WH; Lacaille J; Mes-Masson AM; Parent MÉ; Provencher DM; Richardson L; Siemiatycki J
    Cancer Causes Control; 2017 May; 28(5):393-403. PubMed ID: 28102526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study.
    Risch HA; Marrett LD; Jain M; Howe GR
    Am J Epidemiol; 1996 Aug; 144(4):363-72. PubMed ID: 8712193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for epithelial ovarian tumours of borderline malignancy.
    Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C
    Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressiveness.
    Poole EM; Merritt MA; Jordan SJ; Yang HP; Hankinson SE; Park Y; Rosner B; Webb PM; Cramer DW; Wentzensen N; Terry KL; Tworoger SS
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):429-37. PubMed ID: 23307531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproductive characteristics in relation to ovarian cancer risk by histologic pathways.
    Merritt MA; De Pari M; Vitonis AF; Titus LJ; Cramer DW; Terry KL
    Hum Reprod; 2013 May; 28(5):1406-17. PubMed ID: 23315066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of reproductive factors and exogenous hormone use in relation to ovarian cancer risk among Black women.
    Bethea TN; Palmer JR; Adams-Campbell LL; Rosenberg L
    Cancer Causes Control; 2017 May; 28(5):385-391. PubMed ID: 28025764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?
    Jordan SJ; Green AC; Whiteman DC; Webb PM;
    Gynecol Oncol; 2007 Nov; 107(2):223-30. PubMed ID: 17662378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study.
    Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
    Gynecol Oncol; 2001 Dec; 83(3):575-85. PubMed ID: 11733975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study.
    Huusom LD; Frederiksen K; Høgdall EV; Glud E; Christensen L; Høgdall CK; Blaakaer J; Kjaer SK
    Cancer Causes Control; 2006 Aug; 17(6):821-9. PubMed ID: 16783610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness.
    Modugno F; Ness RB; Wheeler JE
    Ann Epidemiol; 2001 Nov; 11(8):568-74. PubMed ID: 11709277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproductive factors and ovarian cancer risk in African-American women.
    Moorman PG; Alberg AJ; Bandera EV; Barnholtz-Sloan J; Bondy M; Cote ML; Funkhouser E; Peters ES; Schwartz AG; Terry P; Crankshaw S; Wang F; Schildkraut JM
    Ann Epidemiol; 2016 Sep; 26(9):654-62. PubMed ID: 27528178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones.
    Harlow BL; Weiss NS; Roth GJ; Chu J; Daling JR
    Cancer Res; 1988 Oct; 48(20):5849-52. PubMed ID: 3167840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women.
    Moorman PG; Calingaert B; Palmieri RT; Iversen ES; Bentley RC; Halabi S; Berchuck A; Schildkraut JM
    Am J Epidemiol; 2008 May; 167(9):1059-69. PubMed ID: 18303003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
    Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
    Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 U.S. case-control studies. VI. Nonepithelial cancers among adults. Collaborative Ovarian Cancer Group.
    Horn-Ross PL; Whittemore AS; Harris R; Itnyre J
    Epidemiology; 1992 Nov; 3(6):490-5. PubMed ID: 1329996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: A nationwide case-control study.
    Rasmussen ELK; Hannibal CG; Dehlendorff C; Baandrup L; Junge J; Vang R; Kurman RJ; Kjaer SK
    Gynecol Oncol; 2017 Mar; 144(3):571-576. PubMed ID: 28108026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations.
    McGuire V; Felberg A; Mills M; Ostrow KL; DiCioccio R; John EM; West DW; Whittemore AS
    Am J Epidemiol; 2004 Oct; 160(7):613-8. PubMed ID: 15383404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of reproductive factors with risk of non-epithelial ovarian cancer and comparison with serous ovarian cancer.
    Hemmingsen CH; Kjaer SK; Bennetsen AKK; Dehlendorff C; Baandrup L
    Gynecol Oncol; 2021 Aug; 162(2):469-474. PubMed ID: 34016454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition.
    Tsilidis KK; Allen NE; Key TJ; Dossus L; Lukanova A; Bakken K; Lund E; Fournier A; Overvad K; Hansen L; Tjønneland A; Fedirko V; Rinaldi S; Romieu I; Clavel-Chapelon F; Engel P; Kaaks R; Schütze M; Steffen A; Bamia C; Trichopoulou A; Zylis D; Masala G; Pala V; Galasso R; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; van Duijnhoven FJ; Braem MG; Onland-Moret NC; Gram IT; Rodríguez L; Travier N; Sánchez MJ; Huerta JM; Ardanaz E; Larrañaga N; Jirström K; Manjer J; Idahl A; Ohlson N; Khaw KT; Wareham N; Mouw T; Norat T; Riboli E
    Br J Cancer; 2011 Oct; 105(9):1436-42. PubMed ID: 21915124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of pregnancy and the risk of epithelial ovarian cancer.
    Whiteman DC; Siskind V; Purdie DM; Green AC
    Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):42-6. PubMed ID: 12540502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.